e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2010 , Vol 18 , Num 4
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
Genetic Therapy in Hereditary Retinal Diseases
Berkant KADERLİ
Uludağ Üniversitesi Tıp Fakültesi, Göz Hastalıkları A.D., Bursa, Doç. Dr. The eye has several advantages for genetic therapy. First, beacuse of the blood-retina barrier, it is protected against immun reactions. Morover, it’s small size allows gene transporting vectors to rich high concentrations without contaminating other systems. In gene therapy, original coding gene sequence or neuroprotective factor containing viral vectors are given within cells. It is expected that the given original coding gene sequence will lead to sentesis of the original protein and thus cells will survive. Neuroprotective factors are expected to prevent or slow photoreseptors degeneration. Recently, many advancements related to the genetetic therapy in hereditary retinal diseases have been reported. Keywords : Eye, gene therapy, hereditary retinal diseases
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact